Royalty Pharma Sub-Manager, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
RP Royalty Pharma Sub-Manager, LLC | Institutional Filer | — | $344.1M | 4 |
Current Portfolio Holdings
Showing top 8 reported positions by value (Total positions in database: 4)
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | CYTK | Cytokinetics, Incorporated | Healthcare | 980K | $64.6M | 18.78% |
| 2 | CYTK | Cytokinetics, Incorporated | Healthcare | 980K | $62.3M | 18.10% |
| 3 | BCAX | Bicara Therapeutics Inc. Common Stock | Healthcare | 2.4M | $46.7M | 13.57% |
| 4 | BCAX | Bicara Therapeutics Inc. Common Stock | Healthcare | 1.3M | $45.9M | 13.33% |
| 5 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | 3.8M | $36.6M | 10.64% |
| 6 | BHVN | Biohaven Ltd. | Healthcare | 2.9M | $33.2M | 9.64% |
| 7 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | 3.8M | $30.0M | 8.72% |
| 8 | BHVN | Biohaven Ltd. | Healthcare | 2.9M | $24.8M | 7.22% |
Showing 1 to 8 of 8 holdings